Product Code: IRTNTR74050
Technavio has been monitoring the myoglobin market and it is poised to grow by $ 99.2 mn during 2022-2026, accelerating at a CAGR of 4.1% during the forecast period. Our report on the myoglobin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the usage of myoglobin as a biomarker for the diagnosis of ACS and muscle injuries, rising demand for myoglobin reagents from diagnostic laboratories, and the suitability of myoglobin antibodies for immunoblotting, ELISA, and other enzymatic assays.
The myoglobin market analysis includes type segment and geographic landscape.
Technavio's myoglobin market is segmented as below:
By Type
- Animal myoglobin
- Human myoglobin
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the demand for myoglobin instruments for emergency diagnostic patient management as one of the prime reasons driving the myoglobin market growth during the next few years. Also, growing research studies on biomarkers in cardiology and the launch of new myoglobin products to improve diagnostic testing will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the myoglobin market covers the following areas:
- Myoglobin market sizing
- Myoglobin market forecast
- Myoglobin market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading myoglobin market vendors that include Abbott Laboratories, BBI Solutions, Bio Rad Laboratories Inc., bioMerieux SA, Boditech Med Inc., Danaher Corp., DiaSys Diagnostic Systems GmbH, F. Hoffmann La Roche Ltd., General Atomics, HORIBA Ltd., Merck KGaA, OriGene Technologies Inc., Ortho-Clinical Diagnostics Inc., PerkinElmer Inc., Randox Laboratories Ltd., Scripps Laboratories Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Tosoh Corp. Also, the myoglobin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary - Chart on Market Overview
- Exhibit 02: Executive Summary - Data Table on Market Overview
- Exhibit 03: Executive Summary - Chart on Global Market Characteristics
- Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
- Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary - Chart on Incremental Growth
- Exhibit 07: Executive Summary - Data Table on Incremental Growth
- Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
- 5.1 Market segments
- Exhibit 24: Chart on Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
- 5.2 Comparison by Type
- Exhibit 26: Chart on Comparison by Type
- Exhibit 27: Data Table on Comparison by Type
- 5.3 Animal myoglobin - Market size and forecast 2021-2026
- Exhibit 28: Chart on Animal myoglobin - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Animal myoglobin - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Animal myoglobin - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Animal myoglobin - Year-over-year growth 2021-2026 (%)
- 5.4 Human myoglobin - Market size and forecast 2021-2026
- Exhibit 32: Chart on Human myoglobin - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Human myoglobin - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Human myoglobin - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Human myoglobin - Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by Type
- Exhibit 36: Market opportunity by Type ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
- Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 China - Market size and forecast 2021-2026
- Exhibit 62: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.9 Germany - Market size and forecast 2021-2026
- Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.10 Canada - Market size and forecast 2021-2026
- Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.11 UK - Market size and forecast 2021-2026
- Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity By Geographical Landscape
- Exhibit 78: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.3 Abbott Laboratories
- Exhibit 85: Abbott Laboratories - Overview
- Exhibit 86: Abbott Laboratories - Business segments
- Exhibit 87: Abbott Laboratories - Key news
- Exhibit 88: Abbott Laboratories - Key offerings
- Exhibit 89: Abbott Laboratories - Segment focus
- 10.4 Bio Rad Laboratories Inc.
- Exhibit 90: Bio Rad Laboratories Inc. - Overview
- Exhibit 91: Bio Rad Laboratories Inc. - Business segments
- Exhibit 92: Bio Rad Laboratories Inc. - Key news
- Exhibit 93: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 94: Bio Rad Laboratories Inc. - Segment focus
- 10.5 F. Hoffmann La Roche Ltd.
- Exhibit 95: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 96: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 97: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 98: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 99: F. Hoffmann La Roche Ltd. - Segment focus
- 10.6 Merck KGaA
- Exhibit 100: Merck KGaA - Overview
- Exhibit 101: Merck KGaA - Business segments
- Exhibit 102: Merck KGaA - Key news
- Exhibit 103: Merck KGaA - Key offerings
- Exhibit 104: Merck KGaA - Segment focus
- 10.7 OriGene Technologies Inc.
- Exhibit 105: OriGene Technologies Inc. - Overview
- Exhibit 106: OriGene Technologies Inc. - Product / Service
- Exhibit 107: OriGene Technologies Inc. - Key offerings
- 10.8 PerkinElmer Inc.
- Exhibit 108: PerkinElmer Inc. - Overview
- Exhibit 109: PerkinElmer Inc. - Business segments
- Exhibit 110: PerkinElmer Inc. - Key news
- Exhibit 111: PerkinElmer Inc. - Key offerings
- Exhibit 112: PerkinElmer Inc. - Segment focus
- 10.9 Randox Laboratories Ltd.
- Exhibit 113: Randox Laboratories Ltd. - Overview
- Exhibit 114: Randox Laboratories Ltd. - Product / Service
- Exhibit 115: Randox Laboratories Ltd. - Key offerings
- 10.10 Scripps Laboratories Inc.
- Exhibit 116: Scripps Laboratories Inc. - Overview
- Exhibit 117: Scripps Laboratories Inc. - Product / Service
- Exhibit 118: Scripps Laboratories Inc. - Key offerings
- 10.11 Thermo Fisher Scientific Inc.
- Exhibit 119: Thermo Fisher Scientific Inc. - Overview
- Exhibit 120: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 121: Thermo Fisher Scientific Inc. - Key news
- Exhibit 122: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 123: Thermo Fisher Scientific Inc. - Segment focus
- 10.12 Tosoh Corp.
- Exhibit 124: Tosoh Corp. - Overview
- Exhibit 125: Tosoh Corp. - Business segments
- Exhibit 126: Tosoh Corp. - Key offerings
- Exhibit 127: Tosoh Corp. - Segment focus
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 128: Inclusions checklist
- Exhibit 129: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 130: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 131: Research methodology
- Exhibit 132: Validation techniques employed for market sizing
- Exhibit 133: Information sources
- 11.5 List of abbreviations
- Exhibit 134: List of abbreviations
- investments in R and D by biotechnology firms and federal agencies: Biotechnology companies and research organizations are investing significantly in R and D activities to develop new technologies to improve the quality and standards of their products. They are investing in proteomics, drug testing, high-throughput screening, combinational chemistry, and the development of highly innovative environment-friendly biotechnology reagents. Increased R and D has led to improved healthcare access in the US, countries in Europe, as well as in emerging markets such as China and India, which drives the demand for biotechnology reagents.